What is your approach to pancreatic adenocarcinoma s/p surgery with N0/R0 disease and intermediate risk factors with regard to adjuvant chemo-radiation?

With the presentation of RTOG 0848 at ASCO 2024, our practice has changed to offer adjuvant chemoradiation if there is no evidence of distant spread after the completion of any planned adjuvant chemotherapy. Per 0848, we are only offering radiation to patients with tumor of the pancreatic head (body...